{"date":"2026-04-13","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6483-2026-04-13-2306-1y8jjjc","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"23:06:11","subject":"公告本公司與友杏生技醫藥股份有限公司簽署由本公司自主開發之OBM-B01氰化物複方藥物專案（專利名稱：用於上呼吸道給藥之組成物及其給藥方法）委託服務合約","clause":"第8款","fact_date":"2026-04-13","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-04-13 23:06，「公告本公司與友杏生技醫藥股份有限公司簽署由本公司自主開發之OBM-B01氰化物複方藥物專案（專利名稱：用於上呼吸道給藥之」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-04-13-1809-19jyykj","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"18:09:48","subject":"公告本公司經主管機關核准撤銷114年現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-04-13 18:09，「公告本公司經主管機關核准撤銷114年現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-04-13-1720-1qj44hg","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"17:20:47","subject":"公告本公司財務主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-04-13 17:20，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-04-13-1659-1fsrcpi","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"16:59:42","subject":"公告本公司取得歐洲「QUINAZOLINE DERIVATIVES USEFULAS SELECTIVE HDAC6 INHIBITORS」發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-04-13 16:59，「公告本公司取得歐洲「QUINAZOLINE DERIVATIVES USEFULAS SELECTIVE HDAC6 I」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-04-13-1635-8www2v","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"16:35:51","subject":"本公司受邀參加寬量國際主辦之「19th QIC CEO Week」","clause":"第30款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-04-13 16:35，「本公司受邀參加寬量國際主辦之「19th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-04-13-1553-1yg4puh","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-04-13","time":"15:53:21","subject":"公告本公司受邀參加寬量國際主辦之「19th QIC CEO Week」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-04-13 15:53，「公告本公司受邀參加寬量國際主辦之「19th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-04-13-1549-1xrt7ko","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-13","time":"15:49:27","subject":"公告本公司亞比斯 可拉 膠原美粒ABCcolla CollagenADM Scaffold取得泰國醫療器材CLASS 4上市許可。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-04-13 15:49，「公告本公司亞比斯 可拉 膠原美粒ABCcolla CollagenADM Scaffold取得泰國醫療器材CLASS 4」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-13-1544-1aq7iqo","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-13","time":"15:44:48","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-13 15:44，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-13-1514-1aq7iqo","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-13","time":"15:14:29","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-13 15:14，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-04-13-1511-1u4acr4","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-04-13","time":"15:11:34","subject":"(調整召集事由)公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-04-13 15:11，「(調整召集事由)公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-04-13-1501-9dh5qj","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-04-13","time":"15:01:12","subject":"本公司買回股份累積金額達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-04-13 15:01，「本公司買回股份累積金額達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-04-13-1359-rs6v8q","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-04-13","time":"13:59:24","subject":"公告本公司受邀參加元大證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-04-13 13:59，「公告本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}